An international team of researchers led by the University of California San Diego has developed a new strategy to enhance ...

The US company has said it is launching the Phase III trials in the first half of this year after Phase I talks with the US ...

An international team of researchers led by the University of California San Diego has developed a new strategy to enhance ...

VisiRose Inc. (”VisiRose” or the “Company”), a privately-held, clinical-stage biotechnology company developing novel ocular ...

Chase Malackowski was diagnosed with Ewing's Sarcoma at eight years old. After trialing a "single patient Investigational New ...

SLP highlighted its impact on the pharma industry through support of the development of a majority of the drugs approved by ...

Preclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center identified a cocktail of three different drugs that can be used to generate more robust ...

A dozen GLP-1 receptor agonists and coagonists demonstrated effectiveness for weight loss in adults with obesity and without ...

Preclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center have identified a ...

A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...

The investigational new drug application for the nanoparticle drug SNB-101 has been cleared for small cell lung cancer ...

In its latest attempt to bulk up its cancer drug portfolio, AbbVie has signed a new licensing agreement with China-based Simcere Zaiming to develop a treatment for myeloma, a type of blood cancer, in ...